Abstract
Background Access to health services and adequate care is influenced by sex, ethnicity, socio-economic position (SEP) and burden of co-morbidities. However, it is unknown whether the COVID-19 pandemic further deepened these already existing health inequalities.
Methods Participants were from five longitudinal age-homogenous British cohorts (born in 2001, 1990, 1970, 1958 and 1946). A web and telephone-based survey provided data on cancelled surgical or medical appointments, and the number of care hours received during the UK COVID-19 national lockdown. Using binary or ordered logistic regression, we evaluated whether these outcomes differed by sex, ethnicity, SEP and having a chronic illness. Adjustment was made for study-design, non-response weights, psychological distress, presence of children or adolescents in the household, keyworker status, and whether participants had received a shielding letter. Meta-analyses were performed across the cohorts and meta-regression evaluated the effect of age as a moderator.
Findings 14891 participants were included. Females (OR 1·40, 95% confidence interval [1·27,1·55]) and those with a chronic illness (OR 1·84 [1·65-2·05]) experienced significantly more cancellations during lockdown (all p<0·0001). Ethnic minorities and those with a chronic illness required a higher number of care hours during the lockdown (both OR ≈2·00, all p<0·002). Age was not independently associated with either outcome in meta-regression. SEP was not associated with cancellation or care hours.
Interpretation The UK government’s lockdown approach during the COVID-19 pandemic appears to have deepened existing health inequalities, impacting predominantly females, ethnic-minorities and those with chronic illnesses. Public health authorities need to implement urgent policies to ensure equitable access to health and care for all in preparation for a second wave.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the Economic and Social Research Council under the Center for Longitudinal Studies, Resource Center 2015-20, grant number ES/M001660/1, and by the Medical Research Council, grant MC_UU_00019/1. G.C. is supported by British Heart Foundation (MyoFit46 Special Programme Grant SP/20/2/34841), the National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC) and by the NIHR UCL Hospitals Biomedical Research Center. J.C.M. is directly and indirectly supported by the UCL Hospitals NIHR BRC and Biomedical Research Unit at Barts Hospital respectively. DB is supported by the Economic and Social Research Council (grant number ES/M001660/1) and by The Academy of Medical Sciences / Wellcome Trust (Springboard Health of the Public in 2040 award: HOP001/1025). AH receives support from the British Heart Foundation, the Economic and Social Research Council (ESRC), the Horizon 2020 Framework Programme of the European Union, the National Institute on Aging, the National Institute for Health Research University College London Hospitals Biomedical Research Center, the UK Medical Research Council and works in a unit that receives support from the UK Medical Research Council. GC thanks for support the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 819752 DEVORHBIOSHIP - ERC-2018-COG).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UCL/IOE ethics review board: https://www.ucl.ac.uk/ioe/research/research-ethics/ethics-applications-ioe-staff.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
NSHD data is available from: https://www.nshd.mrc.ac.uk/data. Data from the remaining cohorts is available from the UK Data Archive: https://www.data-archive.ac.uk.
